See also our related blog for the Pediatric Preclinical Testing Initiative.

Tuesday, January 20, 2015

Welcoming Matthew (to cc-TDI)


Matthew Svalina joins cc-TDI from Dr. Keller's academic laboratory as a founding member of our scientific team, with an eye on advancing the most promising childhood cancer therapeutics towards clinical trials. Matthew is motivated by the 1 in 5 children diagnosed with cancer for whom survival is still a challenge.

Matthew earned a Bachelor of Science degree in Biological Sciences with a minor in Chemistry from the University of Illinois in 2007. Following completion of his undergraduate degree, Matthew earned a paramedic license through Malcolm X College in Chicago, where he completed his field internship with the Chicago Fire Department on ambulances serving the south side of Chicago. As a member of the Keller lab, Matthew has already co-authored two scientific papers on childhood cancer, with additional studies nearing submission. Under Dr. Keller's mentorship, Matthew leads basic science and preclinical projects in rhabdomyosarcoma and medulloblastoma. Matthew’s career goal is to be a physician-scientist with training and independent research in neuroscience and neuro-oncology.